Literature DB >> 20826813

Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment.

Shuxian Jiang1, Radoslaw Zagozdzon, Meritxell Alberich Jorda, Kalindi Parmar, Yigong Fu, John S Williams, Jodi Anne T Wood, Alexandros Makriyannis, Naheed Banu, Shalom Avraham, Jerome E Groopman, Hava Karsenty Avraham.   

Abstract

Endocannabinoids are lipid signaling molecules that act via G-coupled receptors, CB(1) and CB(2). The endocannabinoid system is capable of activation of distinct signaling pathways on demand in response to pathogenic events or stimuli, hereby enhancing cell survival and promoting tissue repair. However, the role of endocannabinoids in hematopoietic stem and progenitor cells (HSPCs) and their interaction with hematopoietic stem cells (HSC) niches is not known. HSPCs are maintained in the quiescent state in bone marrow (BM) niches by intrinsic and extrinsic signaling. We report that HSPCs express the CB(1) receptors and that BM stromal cells secrete endocannabinoids, anandamide (AEA) (35 pg/10(7) cells), and 2-AG (75.2 ng/10(7) cells). In response to the endotoxin lipopolysaccharide (LPS), elevated levels of AEA (75.6 pg/10(7) cells) and 2-AG (98.8 ng/10(7) cells) were secreted from BM stromal cells, resulting in migration and trafficking of HSPCs from the BM niches to the peripheral blood. Furthermore, administration of exogenous cannabinoid CB(1) agonists in vivo induced chemotaxis, migration, and mobilization of human and murine HSPCs. Cannabinoid receptor knock-out mice Cnr1(-/-) showed a decrease in side population (SP) cells, whereas fatty acid amide hydrolase (FAAH)(-/-) mice, which have elevated levels of AEA, yielded increased colony formation as compared with WT mice. In addition, G-CSF-induced mobilization in vivo was modulated by endocannabinoids and was inhibited by specific cannabinoid antagonists as well as impaired in cannabinoid receptor knock-out mice Cnr1(-/-), as compared with WT mice. Thus, we propose a novel function of the endocannabinoid system, as a regulator of HSPC interactions with their BM niches, where endocannabinoids are expressed in HSC niches and under stress conditions, endocannabinoid expression levels are enhanced to induce HSPC migration for proper hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826813      PMCID: PMC2975171          DOI: 10.1074/jbc.M110.144758

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Hematopoietic stem cells: generation and self-renewal.

Authors:  X Huang; S Cho; G J Spangrude
Journal:  Cell Death Differ       Date:  2007-09-07       Impact factor: 15.828

Review 2.  Haematopoietic stem cells niches: interrelations between structure and function.

Authors:  Alp Can
Journal:  Transfus Apher Sci       Date:  2008-05-16       Impact factor: 1.764

3.  Transmigration of human CD34+ cells.

Authors:  Seiji Fukuda; Louis M Pelus
Journal:  Methods Mol Biol       Date:  2008

Review 4.  Endocannabinoids and the regulation of bone metabolism.

Authors:  I Bab; O Ofek; J Tam; J Rehnelt; A Zimmer
Journal:  J Neuroendocrinol       Date:  2008-05       Impact factor: 3.627

5.  Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation.

Authors:  Jonathan Hoggatt; Pratibha Singh; Janardhan Sampath; Louis M Pelus
Journal:  Blood       Date:  2009-03-26       Impact factor: 22.113

Review 6.  Wnt-related molecules and signaling pathway equilibrium in hematopoiesis.

Authors:  Sachin Malhotra; Paul W Kincade
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

Review 7.  Self-renewal versus differentiation in hematopoietic stem and progenitor cells: a focus on asymmetric cell divisions.

Authors:  Bernd Giebel; Ingmar Bruns
Journal:  Curr Stem Cell Res Ther       Date:  2008-01       Impact factor: 3.828

8.  Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation.

Authors:  Deborah Patinkin; Garry Milman; Aviva Breuer; Ester Fride; Raphael Mechoulam
Journal:  Eur J Pharmacol       Date:  2008-05-15       Impact factor: 4.432

9.  Haematopoietic stem cells depend on Galpha(s)-mediated signalling to engraft bone marrow.

Authors:  Gregor B Adams; Ian R Alley; Ung-Il Chung; Karissa T Chabner; Nathaniel T Jeanson; Cristina Lo Celso; Emily S Marsters; Min Chen; Lee S Weinstein; Charles P Lin; Henry M Kronenberg; David T Scadden
Journal:  Nature       Date:  2009-03-25       Impact factor: 49.962

Review 10.  New perspectives in human stem cell therapeutic research.

Authors:  Alan Trounson
Journal:  BMC Med       Date:  2009-06-11       Impact factor: 8.775

View more
  7 in total

1.  The haematopoietic stem cell niche at a glance.

Authors:  Cristina Lo Celso; David T Scadden
Journal:  J Cell Sci       Date:  2011-11-01       Impact factor: 5.285

Review 2.  Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function.

Authors:  Louis M Pelus; Jonathan Hoggatt
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-21       Impact factor: 3.072

Review 3.  Many mechanisms mediating mobilization: an alliterative review.

Authors:  Jonathan Hoggatt; Louis M Pelus
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

4.  Meloxicam with Filgrastim may Reduce Oxidative Stress in Hematopoietic Progenitor Cells during Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Multiple Myeloma.

Authors:  Andrea M Patterson; Shuhong Zhang; Liqiong Liu; Hongge Li; Pratibha Singh; Yunlong Liu; Sherif S Farag; Louis M Pelus
Journal:  Stem Cell Rev Rep       Date:  2021-09-12       Impact factor: 5.739

5.  Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells.

Authors:  Cristina Maria Costantino; Achla Gupta; Alice W Yewdall; Benjamin M Dale; Lakshmi A Devi; Benjamin K Chen
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

Review 6.  Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review.

Authors:  Yuqi Xin; Anqun Tang; Shuting Pan; Jie Zhang
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

Review 7.  The Endocannabinoid System and Physical Activity-A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders.

Authors:  Tomasz Charytoniuk; Hubert Zywno; Klaudia Berk; Wiktor Bzdega; Adrian Kolakowski; Adrian Chabowski; Karolina Konstantynowicz-Nowicka
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.